{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Johnson & Johnson", "item": "https://www.patentleaderboard.com/2021/company/jnj"}, {"@type": "ListItem", "position": 4, "name": "Catherine Ferrante", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ca_ln:ferrante-1"}]}

Home › 2021 › Johnson & Johnson › Catherine Ferrante

Catherine Ferrante — 1 Patent in 2021

Johnson & Johnson: 1 patents #487 of 1,204Top 45%

Spring House, PA: #13 of 38 inventorsTop 35%

Pennsylvania: #2,483 of 7,685 inventorsTop 35%

Overall (2021): #507,773 of 548,734Top 95%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10894830	Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses	Raluca Verona, Gordon Powers, Nina Chi Sabins, Nikki A. DeAngelis, Sandra Santulli-Marotto +3 more	2021-01-19	$146,074,000

Catherine Ferrante — 1 Patent in 2021

Issued Patents 2021

Patent Widget